A Mortality Prediction Rule for Hematology Patients with Invasive Aspergillosis Based on Serum Galactomannan Kinetics
Open Access
- 24 February 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (2) , 610
Abstract
In invasive aspergillosis (IA), an early and adequate assessment of the response to the initial antifungal therapy remains problematic. We retrospectively analyzed 206 hematology patients with proven or probable IA, and collected serial serum galactomannan (sGM) values and survival status through week 6 and week 12. We created a model for survival at week 6 based on the sGM taken at baseline and on early sGM kinetics. This resulted in a rule predicting that patients with a baseline sGM index >1.4, who failed to lower that index to <0.5 after one week, had a mortality rate of 48.1% at week 6. Conversely, patients presenting with a baseline sGM index ≤1.4 that obtained a negative sGM (<0.5) after one week, had a mortality that was almost five times lower at only 10.1% by week 6. These findings were confirmed in an external cohort from an independent prospective study. In conclusion, sGM kinetics correlate well with treatment outcomes in hematology patients with IA. We present a rule which is easy to use at the bedside and has good accuracy in predicting week 6 survival.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (T004517N)
- Koning Boudewijnstichting (J5810650)
- Michaël Van Waeyenberge Fonds (J5810650)
This publication has 31 references indexed in Scilit:
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Early diagnosis of invasive mould infections and diseaseJournal of Antimicrobial Chemotherapy, 2017
- Galactomannan, β-D-Glucan, and Polymerase Chain Reaction–Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-AnalysisClinical Infectious Diseases, 2016
- Combination Antifungal Therapy for Invasive AspergillosisAnnals of Internal Medicine, 2015
- Diagnosis of Invasive Aspergillosis Using a Galactomannan Assay: A Meta-AnalysisClinical Infectious Diseases, 2006
- Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosisClinical Microbiology and Infection, 2006
- Use of Circulating Galactomannan Screening for Early Diagnosis of Invasive Aspergillosis in Allogeneic Stem Cell Transplant RecipientsThe Journal of Infectious Diseases, 2002
- Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan AntigenemiaAntimicrobial Agents and Chemotherapy, 2002
- Pulmonary Aspergillosis: Early Diagnosis Improves SurvivalRespiration, 1995
- Receptor-Mediated Clearance of Aspergillus GalactomannanThe Journal of Infectious Diseases, 1987